22-09-2026 17:27 via drugs.com

Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL

TUESDAY, Sept. 22, 2026-- Blinatumomab is associated with significantly higher event-free survival among children with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), according to a study published in the Sept. 17 issue of the...

High Intake of Eggs, Peanuts in Pregnancy Does Not Lower Allergy Risk

Gene Mutation Identified That Increases Lung Cancer Risk

What Happens When You Can’t See A Family Doctor Regularly?

Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years

Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis

Cirrhosis Can Recur After Liver Transplant

Kratom Cases Climb Sharply Across The US

MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms

Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds

Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported

Cardiovascular Health And Exercise: How Much Aerobic Activity Do You Really Need?

Mindfulness, Tai Chi Can Ease Pain, Fatigue Among Cancer Survivors

Interest In Dementia Vaccine High In U.S., Survey Finds

Marathons Safe For People With Type 1 Diabetes, Study Says

Desktop versie

Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL

Pharmaceutical news